Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Explore effective ways to find extra work on the side. Increase your earnings and enhance your financial security.
15,574 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A Dream Finders insider sale grabbed attention after the stock dropped nearly 30%. This guide breaks down what know a...
A year after the OBBBA package, the impact on budgets and balance sheets is mixed. Here's a data-driven read on who g...
LNG demand is primed to rise dramatically as the world leans on cleaner fuels. This guide highlights why the trend ma...
As the AI rally continues, XNTK’s 35-stock equal-weight tech approach is being weighed against QQQ’s Nasdaq-100 expos...
Record oil and gas output sits alongside surging electricity bills, fueling voter fury american energy debates ahead ...
Two AI-focused ETFs, CHAT and SOXX, offer very different routes into tech and AI exposure. This guide breaks down whe...
Gap reported a Q4 beat on earnings but a sharp post-earnings slide as margins face tariff pressure. The company raise...
The crisis now in its third week intensified after a missile strike on the U.S. embassy in Baghdad and a fuel facilit...
Palantir stock sits at a valuation well above the market average. This piece breaks down what that 2,500% gap means, ...
Argan stock ascended today as investors cheered stronger profits and a brighter outlook for energy infrastructure tie...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...